Aspen Grove Capital, LLC

Position in PFE — Pfizer Inc

CIK 1806027 AVON, CO

Position in PFE

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$1,525,492

-$231,894 QoQ

Shares Held

63,351

+1.2% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.29%

of 13F equity value

Holder Rank

#1,086

of 2,821 holders

Holding Since

Dec 2022

15 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Aspen Grove Capital, LLC holds $11,919,703 across 10 Drug Manufacturers - General names. PFE ranks #2 (12.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	4,303	$5,161,147
2	PFE	Pfizer Inc This page	63,351	$1,525,492
3	GSK	GSK plc	23,082	$1,209,958
4	AMGN	Amgen Inc	2,888	$1,045,802
5	JNJ	Johnson & Johnson	3,238	$822,354
6	ABBV	AbbVie Inc.	2,252	$566,693
7	MRK	Merck & Co., Inc.	3,683	$473,265
8	AZN	Astrazeneca PLC	2,371	$449,589

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,525,492	63,351	+1.2%	Shares	Sole	2026-08-14
2026-03-31	$1,757,386	62,585	0.0%	Shares	Sole	2026-05-14
2025-12-31	$1,558,366	62,585	+0.4%	Shares	Sole	2026-02-17
2025-09-30	$1,587,556	62,306	+1.5%	Shares	Sole	2025-11-14
2025-06-30	$1,488,020	61,387	-2.5%	Shares	Sole	2025-08-14
2025-03-31	$1,595,051	62,946	+1.2%	Shares	Sole	2025-05-14
2024-12-31	$1,650,431	62,210	-2.2%	Shares	Sole	2025-02-14
2024-09-30	$1,841,278	63,624	-0.1%	Shares	Sole	2024-11-13
2024-06-30	$1,782,326	63,700	+2.8%	Shares	Sole	2024-08-14
2024-03-31	$1,719,001	61,946	-28.7%	Shares	Sole	2024-05-15
2023-12-31	$2,501,476	86,887	-1.1%	Shares	Sole	2024-02-14
2023-09-30	$2,913,685	87,841	-22.8%	Shares	Sole	2023-11-13
2023-06-30	$4,174,257	113,802	+1.0%	Shares	Sole	2023-08-14
2023-03-31	$4,595,140	112,626	-0.5%	Shares	Sole	2023-05-15
2022-12-31	$5,797,396	113,142	—	Shares	Sole	2023-02-14
No filing history on record for this holder in this stock.